Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation

British Journal of Dermatology

Volumn 164, Issue 3, 2011, Pages 586-592

  Gahr, N ^a   Folster Holst R ^a   Weichenthal, M ^a   Christophers, E ^a   Schroder J M ^a   Bartels, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 4; MESSENGER RNA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SKIN BIOPSY; SKIN FIBROBLAST;

ACUTE DISEASE; ADULT; AGED; BIOPSY; CELLS, CULTURED; CHEMOKINE CCL11; CHILD; CHRONIC DISEASE; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79952419144     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10112.x     Document Type: Article

References (42)

1. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-7. (Pubitemid 38544154)
2. Oyoshi MK, He R, Kumar L, et al. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009; 102: 135-226.
3. Coleman R, Trembath RC, Harper JI,. Genetic studies of atopy and atopic dermatitis. Br J Dermatol 1997; 136: 1-5. (Pubitemid 27016166)
4. Werfel T,. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009; 129: 1878-91.
5. Leiferman KM,. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 1991; 24: 1101-12.
6. Walsh GM,. Advances in the immunobiology of eosinophils and their role in disease. Crit Rev Clin Lab Sci 1999; 36: 453-96. (Pubitemid 29535220)
7. Weller PF,. The immunobiology of eosinophils. N Engl J Med 1991; 324: 1110-18.
8. Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144: 1274-81.
9. Leiferman KM, Ackerman SJ, Sampson HA, et al. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985; 313: 282-5. (Pubitemid 15044229)
10. Cara DC, Negrao-Correa D, Teixeira MM,. Mechanisms underlying eosinophil trafficking and their relevance in vivo. Histol Histopathol 2000; 15: 899-920. (Pubitemid 30495193)
11. Schröder J-M, Noso N, Sticherling M, et al. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol 1996; 59: 1-5. (Pubitemid 26054587)
12. Bartels J, Schlüter C, Richter E, et al. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun 1996; 225: 1045-51. (Pubitemid 26319224)
13. Mochizuki M, Bartels J, Mallet AI, et al. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160: 60-8. (Pubitemid 28116715)
14. Mochizuki M, Schröder J-M, Christophers E, et al. IL-4 induces eotaxin in human dermal fibroblasts. Int Arch Allergy Immunol 1999; 120 (Suppl. 1): 19-23. (Pubitemid 29457355)
15. Noso N, Bartels J, Mallet AI, et al. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-α- stimulated dermal fibroblasts. Eur J Biochem 1998; 253: 114-22. (Pubitemid 28182312)
16. Schröder J-M, Mochizuki M,. The role of chemokines in cutaneous allergic inflammation. Biol Chem 1999; 380: 889-96. (Pubitemid 29412746)
17. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97: 604-12. (Pubitemid 26057077)
18. Yawalkar N, Uguccioni M, Scharer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999; 113: 43-8. (Pubitemid 29328157)
19. Schröder J-M, Sticherling M, Henneicke HH, et al. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990; 144: 2223-32. (Pubitemid 20106564)
20. Bonecchi R, Facchetti F, Dusi S, et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 2000; 164: 3862-9. (Pubitemid 30169845)
21. Oskeritzian CA, Wang Z, Kochan JP, et al. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol 1999; 163: 5105-15. (Pubitemid 29501280)
22. Meyyappan M, Atadja PW, Riabowol KT,. Regulation of gene expression and transcription factor binding activity during cellular aging. Biol Signals 1996; 5: 130-8. (Pubitemid 26273306)
23. Cristofalo VJ, Pignolo RJ,. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 1993; 73: 617-38. (Pubitemid 23204854)
24. Shiraha H, Gupta K, Drabik K, et al. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 2000; 275: 19343-51. (Pubitemid 30422908)
25. Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107: 871-7. (Pubitemid 32436921)
26. Chomarat P, Banchereau J,. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17: 1-52. (Pubitemid 29014544)
27. Hoffjan S, Epplen JT,. The genetics of atopic dermatitis: recent findings and future options. J Mol Med 2005; 83: 682-92. (Pubitemid 41225110)
28. Morar N, Willis-Owen SA, Moffatt MF, et al. The genetics of atopic dermatitis. J Allergy Clin Immunol 2006; 118: 24-34. (Pubitemid 43946476)
29. Shirakawa I, Deichmann KA, Izuhara I, et al. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000; 21: 60-4. (Pubitemid 30069614)
30. Hoffjan S, Nicolae D, Ober C,. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res 2003; 4: 14.
31. Callard RE, Hamvas R, Chatterton C, et al. An interaction between the IL-4Ralpha gene and infection is associated with atopic eczema in young children. Clin Exp Allergy 2002; 32: 990-3. (Pubitemid 34779592)
32. Hershey GK, Friedrich MF, Esswein LA, et al. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-5. (Pubitemid 27527768)
33. Kruse S, Japha T, Tedner M, et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96: 365-71. (Pubitemid 29118323)
34. Mitsuyasu H, Izuhara K, Mao XQ, et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19: 119-20.
35. Oiso N, Fukai K, Ishii M,. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 2000; 142: 1003-6. (Pubitemid 30304615)
36. Taha RA, Leung DY, Ghaffar O, et al. In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 1998; 102: 245-50. (Pubitemid 28406912)
37. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-5. (Pubitemid 46990506)
38. Hamid Q, Boguniewicz M, Leung DY,. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870-6. (Pubitemid 24251022)
39. Hamid Q, Naseer T, Minshall EW, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-31. (Pubitemid 26289406)
40. Chan LS, Robinson N, Xu L,. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117: 977-83. (Pubitemid 33001220)
41. Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-61. (Pubitemid 28392277)
42. van Panhuys N, Le Gros G, McConnell MJ,. Epigenetic regulation of Th2 cytokine expression in atopic diseases. Tissue Antigens 2008; 72: 91-7. (Pubitemid 352009808)